newsfilter
← Latest News
FDA Approved Drugs·

Approval of Gemtesa, Nda #213006 (Type 1 - New Molecular Entity)

Approval Date: 12/23/2020; Drug Name: Gemtesa, Nda #213006; Active Ingredients: VIBEGRON; Company: Urovant Sciences Gmbh; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 213006

Company
UROVANT SCIENCES GMBH
Keywords
UROVANT SCIENCES GMBH